← brief for 2026-08-12 · Slowing decline

Finerenone across the proteinuric CKD spectrum — NephJC

Key takeaways

This is a journal club discussing finerenone, a drug that lowers protein in the urine and helps protect the kidneys. Two 2026 papers extended the evidence beyond diabetes, including a preplanned subgroup from a large trial called FIND-CKD focused on people with glomerular disease, a type of kidney damage. The exact number of people in that subgroup was not given here. Because it is a subgroup rather than the main trial result, treat it as promising but not final proof.

Source

Page · Forager · 2026-08-13
https://www.nephjc.com/news/2026/7/20/finerenone-shorts